This company is no longer active
ARYA Sciences Acquisition Corp IV (ARYD) Stock Overview
Arya Sciences Acquisition Corp IV does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ARYD Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
ARYA Sciences Acquisition Corp IV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.64 |
| 52 Week High | US$11.57 |
| 52 Week Low | US$6.25 |
| Beta | -0.0021 |
| 1 Month Change | -42.26% |
| 3 Month Change | -41.50% |
| 1 Year Change | -37.59% |
| 3 Year Change | -34.26% |
| 5 Year Change | n/a |
| Change since IPO | -40.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| ARYD | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | -37.8% | 3.2% | 3.4% |
| 1Y | -37.6% | 23.7% | 29.7% |
Return vs Industry: ARYD underperformed the US Capital Markets industry which returned 28.7% over the past year.
Return vs Market: ARYD underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| ARYD volatility | |
|---|---|
| ARYD Average Weekly Movement | 10.5% |
| Capital Markets Industry Average Movement | 3.7% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: ARYD's share price has been volatile over the past 3 months.
Volatility Over Time: ARYD's weekly volatility has increased from 5% to 11% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | Adam Stone | www.perceptivelife.com/arya4 |
Arya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors.
ARYA Sciences Acquisition Corp IV Fundamentals Summary
| ARYD fundamental statistics | |
|---|---|
| Market cap | US$50.04m |
| Earnings (TTM) | -US$2.54m |
| Revenue (TTM) | n/a |
Is ARYD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARYD income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.54m |
| Earnings | -US$2.54m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.34 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -21.7% |
How did ARYD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/08/01 14:28 |
| End of Day Share Price | 2024/07/31 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ARYA Sciences Acquisition Corp IV is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.